Paul Meister.

Investor Director

Paul is currently a partner at Novalis LifeSciences. He serves as Chairman of Arbor Biotechnologies and Amneal Pharmaceuticals. Previously Paul served as Chairman of Thermo Fisher Scientific and Chairman and CEO of inVentiv Health (now Syneos Health).